Default.asp?SafetyInfoID=238
 mri_brain_scan
 Default.asp
 GenPg.asp?pgname=Disclaimer
 TheList_search.asp
 SafetyInfog.asp
 GenPg.asp?pgname=ScreeningForm
 GenPg.asp?pgname=ProductTesting
 GenPg.asp?pgname=OrderingBooks
 GenPg.asp?pgname=Lectures
 GenPg.asp?pgname=AboutDrShellock
 PriorityEmail.asp
 
 mri_brain_scan
 

                                            Safety Information Article
                      Information on this page is limited by the terms of our Disclaimer.  Please Read!

       TheraSeed Radioactive Seed Implant 

The TheraSeed radioactive seed implant (Theragenics Corporation; now owned by Bard Medical) is used to deliver low-level radiation to the prostate to treat cancer. The TheraSeed radioactive seed is a relatively small implant comprised of a titanium tube with two graphite pellets and a lead marker inside. The outside dimensions of tube are approximately 0.177-inches in length with a diameter of 0.032-inches.

Palladium-103 is the isotope contained in the TheraSeed implant. Because the radiation is so low and the seeds are placed so precisely, virtually all the radiation is absorbed by the prostate. Treatments with the TheraSeed implant may involve placement in the prostate of from 80 to 120 of these devices. These “seeds” are implanted with “spacers” between them and placed according to treatment plans, so that they do not contact one another during their intended “in vivo” use.

Magnetic resonance tests (magnetic field interactions, heating, and artifacts) conducted on the TheraSeed revealed that this implant is acceptable for patients undergoing MR procedures at 3-Tesla or less.

REFERENCES

www.bardmedical.com

www.theraseed.com



_____________________________________________________________________________________
  (c) 2017 by Shellock R & D Services, Inc. and Frank G. Shellock, Ph.D. All Rights Reserved. All copyrights and pertinent trademarks are owned by Shellock R & D Services, Inc. and Frank G. Shellock, Ph.D. No part of the MRISAFETY.COM web site may be reproduced, stored in any retrieval system, or transmitted in any form or by any means, physical, electronic or otherwise, without the prior written permission of Shellock R & D Services, Inc. or Frank G. Shellock, Ph. D. Request for permission to reproduce any information contained on the MRISAFETY.COM web site should be addressed to: frank.shellock@gte.net
Be sure to read our Disclaimer.